Clinical Trials Logo

Estrogen clinical trials

View clinical trials related to Estrogen.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04777929 Completed - Preeclampsia Clinical Trials

The Relationship of Phthalate Exposure During Pregnancy and Preeclampsia

Start date: January 1, 2021
Phase:
Study type: Observational

Phthalates are a group of ubiquitous synthetic endocrine-disrupting chemicals. Fetal and neonatal periods are particularly susceptible to endocrine disorders, which prenatal exposure to phthalates causes. There is increasing evidence concerning the potential endocrine disrupting for phthalate exposure during pregnancy. Prenatal exposure phthalates would disrupt the level of sex hormone in pregnant women, which results in preeclampsia. The relationship of prenatal phthalate exposure with maternal and neonatal outcomes in human beings was often sex-specific associations. Because of the potentially harmful influence of prenatal phthalate exposure, steps should be taken to prevent or reduce phthalate exposure during pregnancy.

NCT ID: NCT04330677 Completed - Memory Clinical Trials

Dissecting the Role of Estradiol in Mediating Gender-specific Anxiolytic and Prosocial Effects of Oxytocin

ESMory
Start date: September 18, 2016
Phase: Phase 1
Study type: Interventional

The study aims to examine a behavioral and neural framework for understanding the sex-specific effects of the neuropeptide oxytocin (OXT). Using hormonal, behavioral and neuroimaging readouts, it is planned to explore the interplay of OXT and estradiol as a potential mechanism mediating sexual dimorphic effects.

NCT ID: NCT00827307 Completed - Ultrasonography Clinical Trials

Zoladex Plus Tamoxifen in Breast Cancer

Start date: June 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to compare Zoladex plus tamoxifen with tamoxifen alone as adjuvant hormonal therapy in pre- or perimenopausal women with early-stage breast cancer in terms of breast density, estrogen levels, lipidemia, endometrial thickness and ultrasonographic abnormalities.